| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/26/2005 | WO2005047284A1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 05/26/2005 | WO2005047283A1 Pyridopyrimidinones |
| 05/26/2005 | WO2005047280A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 05/26/2005 | WO2005047279A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 05/26/2005 | WO2005047266A1 Aryl imidazoles and their use as anti-cancer agents |
| 05/26/2005 | WO2005047258A2 Methods and compositions for selectin inhibition |
| 05/26/2005 | WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | WO2005046698A1 Fused heterocyclic compounds |
| 05/26/2005 | WO2005046682A1 Therapeutic compounds and uses thereof |
| 05/26/2005 | WO2005046612A2 Hydroxy piperidine derivatives to treat gaucher disease |
| 05/26/2005 | WO2005046611A2 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 05/26/2005 | WO2005046588A2 Compounds, compositions, and methods |
| 05/26/2005 | WO2005030791A3 Isoquinolinone potassium channel inhibitors |
| 05/26/2005 | WO2005005600A3 Camptothecin analogs having an e-ring ketone |
| 05/26/2005 | US20050113579 Antitumor agents; formed by refluxing mixture of amonafide with acetic acid |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113404 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 05/26/2005 | US20050113402 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 05/26/2005 | US20050113397 Broad spectrum antifungal agent; 1,6-beta-glucan synthetase inhibitors; pyrido(1,2-a)benzimidazole derivatives or benzo(4,5)imidazo(1,2-a)pyridine derivatives |
| 05/26/2005 | US20050113380 [1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists |
| 05/26/2005 | US20050113379 Corticotropin releasing factor (CRF); affective disorders, anxiety disorders, stress-related disorders, eating disorders and substance abuse; eg 5-(1-Ethyl-propyl)-2-(2-methoxy-4-trifluoromethoxy-phenyl)-3,7-dimethyl-5H-pyrrolo[2,3-b]pyrazine |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 05/26/2005 | US20050113358 Enzyme inhibitors for erectile dysfunction and sexual disorders |
| 05/26/2005 | US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis |
| 05/26/2005 | US20050112487 electroconductive supports having layers containing azo compounds, charge transporting substance, acceptors and phenolic compounds, used in laser printer as well as high speed copiers |
| 05/26/2005 | US20050112482 Where the electron acceptors are phenanthrene, ethylcarbazole, benzoquinones |
| 05/26/2005 | CA2545558A1 Pyridopyrimidinones |
| 05/26/2005 | CA2545435A1 Hydroxy piperidine derivatives to treat gaucher disease |
| 05/26/2005 | CA2545433A1 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 05/26/2005 | CA2545384A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 05/26/2005 | CA2545340A1 Fused heterocyclic compounds |
| 05/26/2005 | CA2544602A1 Therapeutic compounds and uses thereof |
| 05/26/2005 | CA2544247A1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 05/26/2005 | CA2544191A1 Substituted naphthyridinone derivatives |
| 05/26/2005 | CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | CA2543765A1 Methods and compositions for selectin inhibition |
| 05/26/2005 | CA2534342A1 Amino acid prodrugs |
| 05/25/2005 | EP1533312A1 Hetero-bicyclic compounds |
| 05/25/2005 | EP1532209A2 Charge transport compositions and electronic devices made with such compositions |
| 05/25/2005 | EP1532153A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 05/25/2005 | EP1532147A1 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 05/25/2005 | EP1532146A2 A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives |
| 05/25/2005 | EP1532145A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 05/25/2005 | EP1532137A2 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 05/25/2005 | EP1532136A1 Pyridazine derivatives as ligands for gaba receptors |
| 05/25/2005 | EP1531820A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 05/25/2005 | EP1531674A2 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 05/25/2005 | EP1451189B1 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof |
| 05/25/2005 | EP1341791B1 Thioether substituted imidazoquinolines |
| 05/25/2005 | EP1286673B1 Ligands of integrin receptors |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | CN1620456A White light emitting compound, white light emission illuminator, and white light emission organic EL device |
| 05/25/2005 | CN1620455A Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 05/25/2005 | CN1620454A Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 05/25/2005 | CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 05/25/2005 | CN1620325A Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 05/25/2005 | CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 05/25/2005 | CN1620290A Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 05/25/2005 | CN1203069C Substituted piperidines, medicaments containing these compounds, and methods for production thereof |
| 05/25/2005 | CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors |
| 05/24/2005 | US6897315 Method for producing 8-methoxy-quinolinecarboxylic acids |
| 05/24/2005 | US6897314 Process for preparing imidazoquinolinamines |
| 05/24/2005 | US6897310 1,5-methylene-3-benzazepines used in treatment of neurological and psychological disorders,especially withdrawl from nicotine addiction |
| 05/24/2005 | US6897308 Process for the preparation of anti-psychotic 3-[2-[-4-(6-fluoro-1,2-benziosoxazol-3-yl)-1-piperidinyl] ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
| 05/24/2005 | US6897234 Asthma therapy; antiallergens; antiinflammatory agents |
| 05/24/2005 | US6897225 Inhibitors of αLβ2 mediated cell adhesion |
| 05/24/2005 | US6897223 Nitrogen compounds such as Benzyl-8-methyl-5,7-dioxo-1,5,6,7-tetrahydro-(1,2,4)triazolo(1,5-a)pyridine -2-carboxylic acid benzylamide, used for prophylaxis of arthritis, inflammation or cancer |
| 05/24/2005 | US6897222 Pyrido[2,1-a]isoquinoline derivatives |
| 05/24/2005 | US6897221 Urea substituted imidazoquinolines |
| 05/24/2005 | US6897215 6-(6,5-Bicyclopiperazinyl)-1-(1- naphthylenesulphonyl)indole, for treating schizophrenia, depression, cognition and memory dysfunction, attention deficit disorder |
| 05/24/2005 | US6897208 Protein kinase inhibitors |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/19/2005 | WO2005044822A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 05/19/2005 | WO2005044818A2 Imidazo[1,2-a]pyridine anxiolytics |
| 05/19/2005 | WO2005044795A1 Process for the preparation of ccr-2 antagonist |
| 05/19/2005 | WO2005044793A2 Nitrogen-containing fused heterocyclic compounds |
| 05/19/2005 | WO2005044277A1 Protein tyrosine phosphatase 1b (ptp-1b) inhibitors and methods of using the same |
| 05/19/2005 | WO2005044264A1 Ccr-2 antagonist salt |
| 05/19/2005 | WO2005028436A3 Thalidomide analogs as tnf-alpha modulators |
| 05/19/2005 | WO2005010000A3 Aryl-condensed 3-arylpyridine compounds and use thereof for controlling pathogenic fungi |
| 05/19/2005 | WO2004069162A3 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/19/2005 | WO2004037811A8 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/19/2005 | WO2004028540A9 Anti-neurodegenerative agents |
| 05/19/2005 | US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107423 Quinolone antibiotics such as 1-Cyclopropyl-6-fluoro-7-(4-hydroxy-hexahydro-cyclopenta[c]pyrrol-2-yl)-8-methyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, used for treating gramnegative or grampositive bacterial infection in mammals |
| 05/19/2005 | US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 05/19/2005 | US20050107419 E.g., Ethyl 2-[2-(4-fluorophenyl)ethyl]-4-(4-{[(2-furylmethyl)amino]carbonyl}phenyl)-5-oxo-8,9-dihydro-5H,7H-pyrazolo[1',2':1,2]pyrazolo[3,4-b]pyridine-3-carboxylate; analogous compounds based on the 7,8,9,9a-tetrahydro-5H-pyrido[2,3-a]pyrrolizine ring; osteoporous; bone disorders; osteoarthritis |
| 05/19/2005 | US20050107412 Pharmaceutically active compounds |
| 05/19/2005 | US20050107408 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 05/19/2005 | US20050107402 4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 05/19/2005 | US20050107400 4-[2-(4-Fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-2-pyridinamine, used for the prophylaxis or treatment of herpes viral infections in humans |
| 05/19/2005 | US20050107391 E.g., 4-(6-Thiophen-2-yl-imidazo[4,5-b]pyrazin-1-ylmethyl)-phenol and 6-Bromo-1-(4-fluoro-benzyl)-1H-[1,2,3]triazolo[4,5-b]pyrazine; treating lung cancer, and renal cancer |
| 05/19/2005 | US20050107389 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107378 Anxiolytic agents; antidepressants; schizophrenia; Parkinson's disease;headaches; hypotensive agents |
| 05/19/2005 | US20050107373 E.g., 1-phenyl-8-(2-phenyl-cyclohexyl)-1,3,8-triaza-spiro[4.5]decan-4-one; activation of N-methylaspartic acid receptors via Glycine (Gly t-1) inhibition; psychoses; analgesics; neurodegenerative and psychological disorders; schizophrenia; cognition activators; antidepressants; Alzheimer's disease |
| 05/19/2005 | US20050107365 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 05/19/2005 | US20050106709 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 05/19/2005 | DE10346939A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |